ABSTRACT. We compared the growth kinetics of neuropathogenic and nonneuropathogenic equine herpesvirus type 1 (EHV-1) strains in mouse cerebral cortex cells and investigated the relevance of the D/N amino acid change at position 752 of ORF30 in Japanese isolates. Neuropathogenic electropherotype P strains 01c1 and 89c25 exhibited similar growth kinetics to nonneuropathogenic P strain 90c16 in cultured neurons; however, the growth ability of type B strain 97c7 was lower than those of the other strains tested. The amino acid encoded at 752 of ORF30 in 01c1 was asparagic acid; asparagine was encoded in the other EHV-1 strains isolated from Japanese horses. The D/N 752 difference in ORF30 may not be related to replication ability in neurons. KEY WORDS: DNA polymerase, EHV-1, Neuron.J. Vet. Med. Sci. 70(5): 505-511, 2008 In recent years, outbreaks of equine herpesvirus type 1 (EHV-1) myeloencephalopathy have increasingly been reported in horses in Europe and the United States [4]. There have been two reported cases of small outbreaks in Japan. The first occurred during an epizootic EHV-1 respiratory infection in racehorses at the Ritto Training Center in 1989 [17], and the other was associated with epizootic abortions that occurred in Hokkaido in 2001 (Matsumura et al., unpublished data). The neurological symptoms of EHV-1 neurological disorders occur in various degrees, ranging from mild ataxia to paraplegia [4,22]. Based on their histopathology, EHV-1 neurological disorders are not considered a direct result of viral infection of neuronal cells, but rather a result of ischemia, hemorrhage and inflammation of the neural parenchyma, specifically of the neurons, glial cells and ependymal cells, resulting in cerebrospinal vasculitis accompanied by leakage and thrombosis [12,15].Allen et al.[3] described 16 electropherotypes based on DNA fingerprinting of EHV-1. The main electropherotypes are P and B, both of which are currently detected in horse populations in Japan [14,17,20]. EHV-1 isolated from horses with neurological disorders has been characterized as type P but not as type B [18,21].We previously observed differences between EHV-1 P and B in ORF64 encoding infected cell protein 4 (ICP4), which is involved in transcription regulation and interaction with host factors [5,20]. The 3'-end and downstream region of ORF64 in EHV-1 B were replaced with the corresponding regions in EHV-4. EHV-1 B has been suggested to be a natural recombinant of EHV-1 P and EHV-4. Epidemiologically, no neurological disorders caused by EHV-1 B have been reported in horses. Therefore, ORF64 has been suggested to be related to neuropathogenesis of EHV-1. On the other hand, using isolates from Europe, North and South America and Australia, Nugent et al. reported that a single amino acid of EHV-1 DNA polymerase encoded in ORF30 was strongly associated with the outbreak of neuropathogenic versus nonneuropathogenic diseases [19]. They reported that 78 out of 82 (95%) nonneurological isolates investigated encoded A 2254 (amino acid N 752 , a...